NADIRA DELHEM
Inventor
Stats
- 0 US patents issued
- 2 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 2 US Applications Filed
- 17 Total Citation Count
- Dec 23, 2020 Most Recent Filing
- Jun 5, 2015 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| UNIVERSITE PARIS SUD, UNE SOCIETE AYANT UN ESTABLISSEMENT A | 1
| 2015
|
| CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE | 1
| 2015
|
| UNIVERSITE SCIENCES TECHNOLOGIES LILLE | 1
| 2015
|
| INSTITUT GUSTAVE ROUSSY, UNE SOCIETE | 1
| 2015
|
| UNIVERSITE DU DROIT ET DE LA SANTE LILLE 2 | 1
| 2015
|
| CELLVAX, UNE SOCIETE, AYANT UN ESTABLISSEMENT A | 1
| 2015
|
Inventor Addresses
| Address | Duration |
|---|---|
| Marcq En Baroeul, FR | Oct 05, 17 - Oct 05, 17 |
| Marcq en Baroeul, FR | Jan 26, 21 - Apr 15, 21 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
| C07K: | PEPTIDES | 2 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2021/0107,984 | 2021 | Antibody which is Directed Against Galectin-9 and is an Inhibitor of the Suppressor Activity of Regulatory T Lymphocytes | 0 |
| 10899838 | 2021 | Antibody which is directed against galectin-9 and is an inhibitor of the suppressor activity of regulatory T lymphocytes | 0 |
| 2017/0283,499 | 2017 | ANTIBODY WHICH IS DIRECTED AGAINST GALECTIN-9 AND IS AN INHIBITOR OF THE SUPPRESSOR ACTIVITY OF REGULATORY T LYMPHOCYTES | 15 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.